CN111141849A - Liquid phase detection and separation method for positional isomer of dexmedetomidine starting material - Google Patents

Liquid phase detection and separation method for positional isomer of dexmedetomidine starting material Download PDF

Info

Publication number
CN111141849A
CN111141849A CN202010011429.6A CN202010011429A CN111141849A CN 111141849 A CN111141849 A CN 111141849A CN 202010011429 A CN202010011429 A CN 202010011429A CN 111141849 A CN111141849 A CN 111141849A
Authority
CN
China
Prior art keywords
ethanol
dimethylphenyl
dexmedetomidine
starting material
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010011429.6A
Other languages
Chinese (zh)
Other versions
CN111141849B (en
Inventor
燕立波
陆玉玲
刘燕燕
赵见雨
金永华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Skyrun Pharmaceuticals Co ltd
Original Assignee
Jiangsu Skyrun Pharmaceuticals Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Skyrun Pharmaceuticals Co ltd filed Critical Jiangsu Skyrun Pharmaceuticals Co ltd
Priority to CN202010011429.6A priority Critical patent/CN111141849B/en
Publication of CN111141849A publication Critical patent/CN111141849A/en
Application granted granted Critical
Publication of CN111141849B publication Critical patent/CN111141849B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/36Control of physical parameters of the fluid carrier in high pressure liquid systems
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8675Evaluation, i.e. decoding of the signal into analytical information
    • G01N30/8679Target compound analysis, i.e. whereby a limited number of peaks is analysed

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Library & Information Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

The invention discloses a liquid phase detection separation method of a positional isomer of dexmedetomidine starting material, which comprises the following steps: preparing a test solution from a 1- (2, 3-dimethylbenzene) ethanol compound, injecting the test solution into a high performance liquid chromatograph, and detecting and recording a chromatogram under the following chromatographic conditions: octadecylsilane chemically bonded silica is used as a filling agent; taking 0.1% phosphoric acid water solution as a mobile phase A; taking acetonitrile solution as a mobile phase B; the elution mode is gradient elution; the flow rate is 0.9-1.1 ml/min; the detection wavelength is 215-222 nm; the column temperature is 30-40 ℃. According to the technical scheme, the position isomer in the 1- (2, 3-dimethylbenzene) ethanol compound can be effectively separated by adopting the chromatographic conditions.

Description

Liquid phase detection and separation method for positional isomer of dexmedetomidine starting material
Technical Field
The invention relates to the technical field of pharmaceutical analysis, in particular to a liquid phase detection separation method for a positional isomer of dexmedetomidine starting material.
Background
1- (2, 3-dimethylphenyl) ethanol is one of the starting materials in the preparation of dexmedetomidine and is a colorless to pale yellow liquid.
The 1- (2, 3-dimethyl benzene) ethanol compound has 5 position isomer impurities according to the prior synthesis process, and the impurities are shown in the following table:
Figure BDA0002357285390000011
wherein, the position isomer impurity structures in the 1- (2, 3-dimethyl benzene) ethanol compound are similar. At present, the pharmacopoeia of various countries does not contain a detection method for the position isomer impurities of the compound, so that a separation method is needed to obtain the 1- (2, 3-dimethyl benzene) ethanol compound with high purity.
Disclosure of Invention
The invention mainly aims to provide a liquid phase detection separation method for positional isomers of dexmedetomidine starting material, and aims to solve the problem that no separation method is used for separating 1- (2, 3-dimethyl benzene) ethanol compounds and isomers thereof in the prior art.
In order to achieve the above object, the present invention provides a liquid phase detection separation method for positional isomers of dexmedetomidine starting material, comprising the following steps:
preparing a test solution from a 1- (2, 3-dimethylbenzene) ethanol compound, injecting the test solution into a high performance liquid chromatograph, and detecting and recording a chromatogram under the following chromatographic conditions:
octadecylsilane chemically bonded silica is used as a filling agent;
taking 0.1% phosphoric acid water solution as a mobile phase A;
taking acetonitrile solution as a mobile phase B;
the elution mode is gradient elution;
the flow rate is 0.9-1.1 ml/min;
the detection wavelength is 215-222 nm;
the column temperature is 30-40 ℃.
Preferably, the flow rate is 1.0ml/min, the detection wavelength is 220nm, and the column temperature is 30 ℃.
Preferably, the gradient elution is in particular:
Figure BDA0002357285390000021
preferably, the test solution is a solution containing 0.3mg of the 1- (2, 3-dimethylbenzene) ethanol compound per 1 ml.
Preferably, before the detection of the test solution, the method further comprises the following steps:
preparing a mixed solution containing 0.0015mg of each of 1ml of 1- (2, 4-dimethylphenyl) ethanol, 1- (2, 5-dimethylphenyl) ethanol, 1- (2, 6-dimethylphenyl) ethanol, 1- (3, 4-dimethylphenyl) ethanol and 1- (3, 5-dimethylphenyl) ethanol as main components, 0.3mg of 1- (2, 3-dimethylphenyl) ethanol as a system suitability solution;
and (3) injecting the system applicability solution into a high performance liquid chromatograph, and detecting and recording a chromatogram under the chromatographic condition.
The technical scheme of the invention is that octadecylsilane chemically bonded silica is used as a filling agent; the 1- (2, 3-dimethyl benzene) ethanol compound can be effectively separated from various position isomers by gradient elution with 0.1% phosphoric acid water solution as a mobile phase A and acetonitrile solution as a mobile phase B.
Drawings
FIG. 1 is a liquid phase detection chromatogram of a positional isomer of dexmedetomidine starting material in example 1;
FIG. 2 is a liquid phase detection chromatogram of a positional isomer of dexmedetomidine starting material in example 2;
FIG. 3 is a liquid phase detection chromatogram of the positional isomer of dexmedetomidine starting material in example 3.
Detailed Description
The present invention will be described in further detail below by way of examples, but it should not be construed that the scope of the subject matter of the present invention is limited to the following examples. Such changes and modifications as would normally occur to one skilled in the art to which the invention relates are deemed to be within the scope and ambit of the invention as defined by the appended claims.
The invention provides a liquid phase detection separation method of a positional isomer of dexmedetomidine starting material, which comprises the following steps:
preparing a mixed solution containing 0.0015mg of each of 1ml of 1- (2, 4-dimethylphenyl) ethanol A-1, 1- (2, 5-dimethylphenyl) ethanol A-2, 1- (2, 6-dimethylphenyl) ethanol A-3, 1- (3, 4-dimethylphenyl) ethanol A-4 and 1- (3, 5-dimethylphenyl) ethanol A-5 as main components, 0.3mg of each of 1- (2, 3-dimethylphenyl) ethanol positional isomers, 1- (2, 3-dimethylphenyl) ethanol and 1- (2, 3-dimethylphenyl) ethanol, and accurately measuring 10ul of the system suitability solution to inject into a liquid chromatograph to record a chromatogram, wherein the system suitability is characterized in that the positional isomers of 1- (3, 4-dimethylphenyl) ethanol, 1- (2, 3-dimethylphenyl) ethanol and 1- (2), the 5-dimethylphenyl) ethanol, the 1- (2, 6-dimethylphenyl) ethanol and the 1- (3, 5-dimethylphenyl) ethanol sequentially peak, and the system has the following suitability requirement: the separation degree of the main peak and the adjacent impurity peak is not less than 1.5.
Preparing a solution containing 0.3mg of the 1- (2, 3-dimethylbenzene) ethanol compound in each 1ml as a test solution, and precisely measuring 10ul of the test solution to be injected into a liquid chromatograph. Wherein the mobile phase A is 0.1% phosphoric acid aqueous solution, and is prepared by adding 1.0ml phosphoric acid into 1000ml water and mixing; the mobile phase B is acetonitrile solution, an ultraviolet detector is adopted, the detection wavelength can be 215-222 nm, and the flow rate can be 0.9-1.1 ml/min; the column temperature can be 30-40 ℃ and elution is carried out according to the elution gradient shown in table 1:
TABLE 1 gradiometer
Figure BDA0002357285390000031
Example 1
High performance liquid chromatograph: agilent1260 (Agilent);
a chromatographic column: YMC-Pack ODS-AQ (250X 4.6mm, 5 μm)
Mobile phase A: adding 1.0ml phosphoric acid into 1000ml water and mixing uniformly to obtain the product
Mobile phase B: acetonitrile
Gradient elution procedure:
the flow rate is 1.0 ml/min;
the detection wavelength is 220 nm;
the column temperature was 40 ℃.
The implementation steps are as follows: preparing a solution containing 0.3mg of 1- (2, 3-dimethylbenzene) ethanol compound per 1ml as a test solution, precisely measuring 10ul of the test solution, injecting into a liquid chromatograph, recording chromatogram, and obtaining the results shown in Table 2 (the corresponding liquid chromatogram is shown in figure 1)
Table 2 example 1 liquid chromatography test results
Impurities Retention time Degree of separation Symmetry factor
A-1/A-2 20.663 1.09 N.A
A-3 21.000 1.52 N.A
A-4 20.320 1.11 N.A
A-5 21.463 16.91 0.99
1- (2, 3-Dimethylbenzene) ethanol 19.633 2.23 1.01
Therefore, adjacent isomer peaks and isomer peaks of the 1- (2, 3-dimethylbenzene) ethanol peak can be effectively separated, and the separation degree is larger than 1.0.
Example 2
High performance liquid chromatograph: agilent1260 (Agilent);
a chromatographic column: YMC-Pack ODS-AQ (250X 4.6mm, 5 μm)
Mobile phase A: adding 1.0ml phosphoric acid into 1000ml water and mixing uniformly to obtain the product
Mobile phase B: acetonitrile
Gradient elution procedure:
the flow rate is 0.9 ml/min;
the detection wavelength is 215 nm;
the column temperature was 35 ℃.
The implementation steps are as follows: preparing a solution containing 0.3mg of 1- (2, 3-dimethylbenzene) ethanol compound per 1ml as a test solution, precisely measuring 10ul of the test solution, injecting into a liquid chromatograph, recording chromatogram, and obtaining the results shown in Table 3 (the corresponding liquid chromatogram is shown in figure 2)
Table 3 example 2 liquid chromatography test results
Figure BDA0002357285390000041
Figure BDA0002357285390000051
Therefore, adjacent isomer peaks and isomer peaks of the 1- (2, 3-dimethylbenzene) ethanol peak can be effectively separated, and the separation degree is larger than 1.0.
Example 3
High performance liquid chromatograph: agilent1260 (Agilent);
a chromatographic column: YMC-Pack ODS-AQ (250X 4.6mm, 5 μm)
Mobile phase A: adding 1.0ml phosphoric acid into 1000ml water and mixing uniformly to obtain the product
Mobile phase B: acetonitrile
Gradient elution procedure:
the flow rate is 1.1 ml/min;
the detection wavelength is 215 nm;
the column temperature was 35 ℃.
The implementation steps are as follows: preparing a solution containing 0.3mg of 1- (2, 3-dimethylbenzene) ethanol compound per 1ml as a test solution, precisely measuring 10ul of the test solution, injecting into a liquid chromatograph, recording chromatogram, and obtaining the results shown in Table 4 (the corresponding liquid chromatogram is shown in figure 3)
Table 4 example 3 liquid chromatography test results
Impurities Retention time Degree of separation Symmetry factor
A-1/A-2 20.928 1.15 N.A
A-3 21.282 1.50 N.A
A-4 20.585 1.12 N.A
A-5 21.738 54.07 1.00
1- (2, 3-Dimethylbenzene) ethanol 19.898 2.23 1.01
Therefore, adjacent isomer peaks and isomer peaks of the 1- (2, 3-dimethylbenzene) ethanol peak can be effectively separated, and the separation degree is larger than 1.0.
The above description is only a part of or preferred embodiments of the present invention, and neither the text nor the drawings should be construed as limiting the scope of the present invention, and all equivalent structural changes, which are made by using the contents of the present specification and the drawings, or any other related technical fields, are included in the scope of the present invention.

Claims (5)

1. A liquid phase detection separation method for positional isomers of dexmedetomidine starting material is characterized by comprising the following steps:
preparing a test solution from a 1- (2, 3-dimethylbenzene) ethanol compound, injecting the test solution into a high performance liquid chromatograph, and detecting and recording a chromatogram under the following chromatographic conditions:
octadecylsilane chemically bonded silica is used as a filling agent;
taking 0.1% phosphoric acid water solution as a mobile phase A;
taking acetonitrile solution as a mobile phase B;
the elution mode is gradient elution;
the flow rate is 0.9-1.1 ml/min;
the detection wavelength is 215-222 nm;
the column temperature is 30-40 ℃.
2. The method for the liquid-phase detection and separation of a positional isomer of dexmedetomidine starting material as set forth in claim 1, characterized in that the flow rate is 1.0ml/min, the detection wavelength is 220nm, and the column temperature is 30 ℃.
3. The method for the liquid-phase detection and separation of a positional isomer of dexmedetomidine starting material as claimed in claim 1, characterized in that the gradient elution is specifically:
Figure FDA0002357285380000011
4. the method for the liquid-phase separation and detection of a positional isomer of dexmedetomidine starting material as set forth in claim 1, characterized in that the test solution contains 0.3mg of 1- (2, 3-dimethylphenyl) ethanol compound per 1 ml.
5. The method for the liquid-phase separation and detection of a positional isomer of dexmedetomidine starting material as set forth in claim 1, further comprising the steps of, before the detection of the test solution:
preparing a mixed solution containing 0.0015mg of each of 1ml of 1- (2, 4-dimethylphenyl) ethanol, 1- (2, 5-dimethylphenyl) ethanol, 1- (2, 6-dimethylphenyl) ethanol, 1- (3, 4-dimethylphenyl) ethanol and 1- (3, 5-dimethylphenyl) ethanol as main components, 0.3mg of 1- (2, 3-dimethylphenyl) ethanol as a system suitability solution;
and (3) injecting the system applicability solution into a high performance liquid chromatograph, and detecting and recording a chromatogram under the chromatographic condition.
CN202010011429.6A 2020-01-06 2020-01-06 Liquid phase detection separation method for positional isomer of dexmedetomidine initial raw material Active CN111141849B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010011429.6A CN111141849B (en) 2020-01-06 2020-01-06 Liquid phase detection separation method for positional isomer of dexmedetomidine initial raw material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010011429.6A CN111141849B (en) 2020-01-06 2020-01-06 Liquid phase detection separation method for positional isomer of dexmedetomidine initial raw material

Publications (2)

Publication Number Publication Date
CN111141849A true CN111141849A (en) 2020-05-12
CN111141849B CN111141849B (en) 2023-11-03

Family

ID=70523737

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010011429.6A Active CN111141849B (en) 2020-01-06 2020-01-06 Liquid phase detection separation method for positional isomer of dexmedetomidine initial raw material

Country Status (1)

Country Link
CN (1) CN111141849B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113325096A (en) * 2021-05-08 2021-08-31 石家庄四药有限公司 Detection method of 1- (2, 3-dimethylphenyl) ethanol related substances

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106083724A (en) * 2016-08-02 2016-11-09 江苏恒瑞医药股份有限公司 A kind of preparation method of dexmedetomidine
CN106442763A (en) * 2016-08-31 2017-02-22 辰欣药业股份有限公司 Method for detecting related substances of dexmedetomidine hydrochloride raw material or preparation
CN107402262A (en) * 2016-05-20 2017-11-28 湖北生物医药产业技术研究院有限公司 Determine the method about content of material in dexmedetomidine hydrochloride bulk drug
CN108872431A (en) * 2018-07-09 2018-11-23 成都倍特药业有限公司 A method of detection 4- (1- (2,5- 3,5-dimethylphenyl) ethyl) -1H- imidazoles or/and its hydrochloride
CN109081811A (en) * 2018-09-19 2018-12-25 南京正大天晴制药有限公司 Related substance of dexmedetomidine hydrochloride and preparation method thereof
CN109580854A (en) * 2018-12-03 2019-04-05 石药银湖制药有限公司 Detection method in relation to substance in a kind of dexmedetomidine hydrochloride raw material or preparation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107402262A (en) * 2016-05-20 2017-11-28 湖北生物医药产业技术研究院有限公司 Determine the method about content of material in dexmedetomidine hydrochloride bulk drug
CN106083724A (en) * 2016-08-02 2016-11-09 江苏恒瑞医药股份有限公司 A kind of preparation method of dexmedetomidine
CN106442763A (en) * 2016-08-31 2017-02-22 辰欣药业股份有限公司 Method for detecting related substances of dexmedetomidine hydrochloride raw material or preparation
CN108872431A (en) * 2018-07-09 2018-11-23 成都倍特药业有限公司 A method of detection 4- (1- (2,5- 3,5-dimethylphenyl) ethyl) -1H- imidazoles or/and its hydrochloride
CN109081811A (en) * 2018-09-19 2018-12-25 南京正大天晴制药有限公司 Related substance of dexmedetomidine hydrochloride and preparation method thereof
CN109580854A (en) * 2018-12-03 2019-04-05 石药银湖制药有限公司 Detection method in relation to substance in a kind of dexmedetomidine hydrochloride raw material or preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李鸿雁;张顺利;刘珍仁;周亭;蔡正艳;周伟澄;: "HPLC法测定盐酸右美托咪定有关物质" *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113325096A (en) * 2021-05-08 2021-08-31 石家庄四药有限公司 Detection method of 1- (2, 3-dimethylphenyl) ethanol related substances

Also Published As

Publication number Publication date
CN111141849B (en) 2023-11-03

Similar Documents

Publication Publication Date Title
CN105651927B (en) RT-HPLC detection method for valdecoxib/parecoxib related substances
CN111141850B (en) Liquid phase detection separation method for related substances of acetaminophen bulk drug
CN109470799A (en) The purity and impurity position finding and detection method of Fmoc-Arg (Pbf)-OH
CN105467021B (en) A kind of method in relation to substance in HPLC method separation determination paricalcitol bulk pharmaceutical chemicals and preparation
CN103076421B (en) Analytic method for related substance examination of rebamipide
CN111141849A (en) Liquid phase detection and separation method for positional isomer of dexmedetomidine starting material
CN107179369B (en) Method for detecting guanfacine hydrochloride related substances by using high performance liquid chromatography
CN106483202B (en) Method for separating and measuring alitretinoin and isomers
CN111380993B (en) Method for analyzing related substances of roxasistat
CN115290777B (en) Detection method of calcipotriol liniment related substances
CN111189937B (en) Liquid phase detection separation method for related substances of aspirin bulk drug
CN111060621A (en) Method for detecting cefoperazone sodium and sulbactam sodium related substances for injection
CN116381068A (en) High performance liquid chromatography for separating and detecting related substances of Mabalo Sha Weizhong
CN107655986B (en) Detection method of related substances of vipatavir
CN108872405A (en) A kind of HPLC analyzing detecting method of the lodoxamide tromethamine in relation to substance
CN110412164B (en) Method for detecting related substances of mexiletine hydrochloride
CN108445091B (en) HPLC analysis method of estrone related substances
CN107656005B (en) Method for separating and determining erlotinib hydrochloride and potential impurities
CN112630313A (en) High performance liquid phase resolution method of (S) -3-hydroxytetrahydrofuran enantiomer
CN105823828A (en) Detection method of 1-(carbamoyl)methyl-4-hydroxy-2-pyrrolidone chiral isomer
CN114062567B (en) Separation and detection method of (1R, 2S) -2- (3, 4-difluorophenyl) cyclopropylamine hydrochloride and related substances thereof
CN112816580B (en) Impurity detection method for sertaconazole nitrate suppository
CN115184527B (en) Detection method of heliotropin impurity
CN113419004B (en) Method for detecting impurities in methyl 3-amino-4-methylbenzoate
CN113406236B (en) Method for detecting impurities in 1- (3-pyridyl) -3- (dimethylamino) -2-propylene-1-ketone

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Liquid phase detection and separation method for positional isomers of starting materials of dexmedetomidine

Effective date of registration: 20231208

Granted publication date: 20231103

Pledgee: Bank of Nanjing Co.,Ltd. Nanjing Chengnan sub branch

Pledgor: SKYRUN PHARMA Co.,Ltd.

Registration number: Y2023980070258

PE01 Entry into force of the registration of the contract for pledge of patent right